Company
Headquarters: Sao Paulo, SP, Brazil
CEO: Mr. Paulo Junqueira Moll
R$61.45 Billion
BRL as of Jan. 1, 2025
US$9.94 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Rede D'Or São Luiz S.A. operates a network of hospitals in Brazil. The company provides services in the medical areas of neurology, oncology, hemangioma, lymphangioma, lymphatic malformation, vascular anomaly and tumor, vascular surgery, radiology, interventional radiology, and pathology, as well as pediatric cardiology, oncology and hematology, and surgery. It operates 51 own hospitals, 1 managed hospital, and 47 oncology clinics with 9,000 beds, as well as provides other services, such as blood bank, dialysis, and ambulatories of various specialties in the states of Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District; and has a robot surgery facilities in Brazil. The company was formerly known as Hospital Maternidade São Luiz S.A. Rede D'Or São Luiz S.A. was founded in 1977 and is headquartered in São Paulo, Brazil.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | R$48.35 B |
EBITDA | R$11.47 B |
Gross Profit TTM | R$8.67 B |
Profit Margin | 6.68% |
Operating Margin | 14.26% |
Quarterly Revenue Growth | 7.70% |
Rede D'Or São Luiz SA has the following listings and related stock indices.
Stock: Bovespa: RDOR3 wb_incandescent